Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethinyl estradiol is a synthetic estrogen widely used as the estrogenic component in combined oral contraceptives and other hormonal therapies. It acts as an agonist of the estrogen receptor, mimicking the effects of natural estrogens like estradiol but with greater oral bioavailability and metabolic stability. Its primary mechanism is suppression of gonadotropins (luteinizing hormone and follicle-stimulating hormone), leading to inhibition of ovulation. Additional contraceptive effects include thickening cervical mucus to impede sperm penetration and altering endometrial lining to prevent implantation. Ethinyl estradiol has also been used in treating menopausal symptoms, gynecological disorders, certain hormone-sensitive cancers, acne, and moderate-to-severe vasomotor symptoms[1][7][9]. It was developed in the 1930s and introduced for medical use in 1943[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethinyl estradiol.